{"TopicDetails": {"type": 0, "ccm2Id": 45032582, "cftId": 0, "identifier": "HORIZON-JU-GH-EDCTP3-2022-CALL1-01-03", "title": "Genomic epidemiology for surveillance and control of poverty-related and emerging/re-emerging infections in sub-Saharan Africa", "publicationDateLong": 1652227200000, "callIdentifier": "HORIZON-JU-GH-EDCTP3-2022-01", "callTitle": "Research and Innovation actions supporting the global health EDCTP3 Joint Undertaking", "callccm2Id": 45032759, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43108390, "abbreviation": "HORIZON", "description": "Horizon Europe Framework Programme (HORIZON)"}, "programmeDivision": [{"id": 43108557, "abbreviation": "HORIZON.2.1", "description": "Health"}, {"id": 43108541, "abbreviation": "HORIZON.2", "description": "Global Challenges and European Industrial Competitiveness"}], "topicMGAs": [], "tags": ["Genomic epidemiology", "genomic sequencing", "FAIR data", "global health", "genomic surveillance", "infectious diseases", "re-emerging infections", "health", "antimicrobial resistant infection", "public health", "data platform", "africa", "emerging infections", "poverty-related diseases", "national public health institutions", "epidemiology"], "keywords": ["Global health", "Public health", "Genomics", "EOSC and FAIR data", "Emerging Epidemics", "Infectious diseases", "Public health policies", "Prevention and treatment of infection by pathogens", "Africa", "Public health and epidemiology", "International Cooperation", "Health"], "flags": ["EoscAndFairData", "Africa", "EC-WORLD"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "typeOfMGA": [{"id": 43027846, "abbreviation": "HORIZON-AG", "description": "HORIZON Action Grant Budget-Based"}]}], "plannedOpeningDate": "11 May 2022", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["30 August 2022"]}], "latestInfos": [{"approvalDate": "Oct 7, 2022 10:57:19 AM", "lastChangeDate": "Oct 7, 2022 10:57:19 AM", "content": "<p><span lang=\"EN-IE\" style=\"font-size: 10.5pt; line-height: 107%; font-family: &quot;inherit&quot;, serif; color: rgb(51, 51, 51); border: 1pt none windowtext; padding: 0cm;\">Call </span><span lang=\"EN-IE\">HORIZON-JU-GH-EDCTP3-2022-01</span><span lang=\"EN-IE\" style=\"font-size: 10.5pt; line-height: 107%; font-family: &quot;inherit&quot;, serif; color: rgb(51, 51, 51); border: 1pt none windowtext; padding: 0cm;\"> closed on 30 August 2022. A total of 92 proposals were submitted. The breakdown per topic is:</span></p>\r\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 3.75pt 18.75pt; text-indent: -18pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><!--[if !supportLists]--><span lang=\"EN-IE\" style=\"font-size:10.0pt;mso-bidi-font-size:10.5pt;font-family:Symbol;&#10;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-IE\" style=\"font-size:10.5pt;font-family:&quot;inherit&quot;,serif;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">HORIZON-JU-GH-EDCTP3-2022-CALL1-01-01: 40 proposals&nbsp;</span><span lang=\"EN-IE\" style=\"font-size:10.5pt;font-family:&#10;&quot;inherit&quot;,serif;mso-bidi-font-family:Calibri;color:#333333;border:none windowtext 1.0pt;&#10;mso-border-alt:none windowtext 0cm;padding:0cm;mso-ansi-language:EN-IE;&#10;mso-fareast-language:FR-BE\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 3.75pt 18.75pt; text-indent: -18pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><!--[if !supportLists]--><span lang=\"EN-IE\" style=\"font-size:10.0pt;mso-bidi-font-size:10.5pt;font-family:Symbol;&#10;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-IE\" style=\"font-size:10.5pt;font-family:&quot;inherit&quot;,serif;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">HORIZON-JU-GH-EDCTP3-2022-CALL1-01-02: 14 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 3.75pt 18.75pt; text-indent: -18pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><!--[if !supportLists]--><span lang=\"EN-IE\" style=\"font-size:10.0pt;mso-bidi-font-size:10.5pt;font-family:Symbol;&#10;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-IE\" style=\"font-size:10.5pt;font-family:&quot;inherit&quot;,serif;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">HORIZON-JU-GH-EDCTP3-2022-CALL1-01-03: 20 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 3.75pt 18.75pt; text-indent: -18pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><!--[if !supportLists]--><span lang=\"EN-IE\" style=\"font-size:10.0pt;mso-bidi-font-size:10.5pt;font-family:Symbol;&#10;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-IE\" style=\"font-size:10.5pt;font-family:&quot;inherit&quot;,serif;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">HORIZON-JU-GH-EDCTP3-2022-CALL1-01-04:&nbsp; 2 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 3.75pt 18.75pt; text-indent: -18pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><!--[if !supportLists]--><span lang=\"EN-IE\" style=\"font-size:10.0pt;mso-bidi-font-size:10.5pt;font-family:Symbol;&#10;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-IE\" style=\"font-size:10.5pt;font-family:&quot;inherit&quot;,serif;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">HORIZON-JU-GH-EDCTP3-2022-CALL1-01-05: 16 proposals<o:p></o:p></span></p>\r\n<p><span lang=\"EN-IE\" style=\"font-size:10.5pt;line-height:107%;font-family:&quot;inherit&quot;,serif;&#10;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:&#10;&quot;Times New Roman&quot;;mso-bidi-theme-font:minor-bidi;color:#333333;border:none windowtext 1.0pt;&#10;mso-border-alt:none windowtext 0cm;padding:0cm;mso-ansi-language:EN-IE;&#10;mso-fareast-language:FR-BE;mso-bidi-language:AR-SA\">Evaluation results are expected to be communicated on Friday 21 November 2022 at the earliest.</span></p>"}], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3418887": [{"action": "HORIZON-JU-GH-EDCTP3-2022-CALL1-01-05 - HORIZON-JU-CSA HORIZON JU Coordination and Support Actions", "plannedOpeningDate": "11 May 2022", "deadlineModel": "single-stage", "deadlineDates": ["30 August 2022"], "budgetYearMap": {"2022": 5000000}, "expectedGrants": 8, "minContribution": 600000, "maxContribution": 600000, "budgetTopicActionMap": {}}], "3418889": [{"action": "HORIZON-JU-GH-EDCTP3-2022-CALL1-01-04 - HORIZON-JU-CSA HORIZON JU Coordination and Support Actions", "plannedOpeningDate": "11 May 2022", "deadlineModel": "single-stage", "deadlineDates": ["30 August 2022"], "budgetYearMap": {"2022": 1000000}, "expectedGrants": 1, "minContribution": 1000000, "maxContribution": 1000000, "budgetTopicActionMap": {}}], "3418891": [{"action": "HORIZON-JU-GH-EDCTP3-2022-CALL1-01-02 - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "11 May 2022", "deadlineModel": "single-stage", "deadlineDates": ["30 August 2022"], "budgetYearMap": {"2022": 30850000}, "expectedGrants": 5, "minContribution": 6000000, "maxContribution": 8000000, "budgetTopicActionMap": {}}], "3418893": [{"action": "HORIZON-JU-GH-EDCTP3-2022-CALL1-01-03 - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "11 May 2022", "deadlineModel": "single-stage", "deadlineDates": ["30 August 2022"], "budgetYearMap": {"2022": 22000000}, "expectedGrants": 4, "minContribution": 5000000, "maxContribution": 5000000, "budgetTopicActionMap": {}}], "3418895": [{"action": "HORIZON-JU-GH-EDCTP3-2022-CALL1-01-01 - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "11 May 2022", "deadlineModel": "single-stage", "deadlineDates": ["30 August 2022"], "budgetYearMap": {"2022": 38030000}, "expectedGrants": 9, "minContribution": 4000000, "maxContribution": 4000000, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2022"]}, "description": "<SPAN class=\"topicdescriptionkind\">ExpectedOutcome</SPAN>:<p>Whilst 2021 has seen an unprecedented expansion in global genomic sequencing capacity for SARS-CoV-2 also in Africa, many challenges remain. The translation of genomic data to inform public health decision making is needed to realize the full impact of this sequencing capacity. In order to achieve this public health impact, there needs to be improved integration of genomics capabilities with complementary disciplines, in particular epidemiology. Purposeful use of genomic sequencing beyond COVID-19 through improving the ability to link genomic sequencing data to clinical and epidemiological data has the opportunity to strengthen both epidemiological research and genomic surveillance in order to create integrated surveillance systems to monitor infectious diseases in sub-Saharan Africa.</p><p>This topic aims to support activities to strengthen genomic epidemiology and its application to inform public health decision making. To that end, proposals under this topic should aim to deliver results that are directed, tailored towards, and contributing to all of the following expected outcomes:</p><ul level=\"0\"><li>Public health professionals and researchers in sub-Saharan Africa have a better understanding of poverty-related and emerging/re-emerging infectious diseases affecting these countries and use genomic epidemiology evidence as part of surveillance and disease control programmes;</li><li>Public health authorities have access to genomic epidemiology data and evidence to better develop and implement informed public health policies in sub-Saharan Africa;</li><li>More researchers and public health professionals (both genomics and epidemiology specialists) have competencies in genomic epidemiology, including how to design studies using genomic epidemiology and how to use and interpret data to answer questions of public health significance in sub-Saharan Africa;</li><li>Researchers and public health professionals have access to improved and integrated research and surveillance infrastructure and capabilities that enables the combination of genomic and epidemiology data for the understanding of infectious disease epidemiology and the development of new, low-cost, easy-to-implement solutions for improved delivery of public health interventions for vulnerable populations in low-resource settings;</li><li>Genomic epidemiology data are leveraged to help inform the design, development, and prioritization of public health products such as diagnostics, therapeutics, and vaccines that are affordable, accessible, and impactful for populations across sub-Saharan Africa;</li><li>Genomic epidemiology capabilities and capacity are strengthened at National Public Health Institutions and regional public health organizations in sub-Saharan Africa;</li><li>More researchers and public health professionals at the early stages of their research and/or public health career (e.g. Master\u2019s, PhD or post-doctoral level) are able to develop their own scientific career in sub-Saharan Africa and/or establish themselves as scientific and public health leaders in sub-Saharan Africa.</li> </ul>\n<SPAN class=\"topicdescriptionkind\">Objective</SPAN>:<p><strong><u>Collaboration between the Global Health EDCTP3 JU and the contributing partner Bill &amp; Melinda Gates Foundation</u> </strong></p><p>The collaboration between the Global Health EDCTP3 Joint Undertaking and the Bill &amp; Melinda Gates Foundation aims to leverage the genomic sequencing capacity being built in Africa to support epidemiology and surveillance of endemic and epidemic pathogens. In order to achieve this, partnerships between epidemiology sites (such as population cohorts and clinical trial sites) and genomic sequencing labs in national public health institutes (NPHIs) are needed, sharing and leveraging resources and expertise.</p><p>The establishment of the Africa Pathogen Genomics Initiative (Africa PGI)<sup><a target=_self href=#fn1 id=r1>[1]</a></sup> with Africa Centre for Disease Control and Prevention (Africa CDC), coupled with the accelerated interest in genomic surveillance due to the COVID-19 pandemic has led to increasing capacity for genomic sequencing in Africa. There is an opportunity to advance the impact of genomic surveillance in Africa by better integrating it with epidemiology expertise and study infrastructure. The integration of epidemiology and genomics, so-called \u2018genomic epidemiology\u2019, would enable countries in Africa to better understand the epidemiology of infectious pathogens, characterize pathogens, and support public health product and intervention design and effectiveness monitoring. While expertise and resources for both epidemiology and genomics exists in Africa, linking the Africa PGI to the Global Health EDCTP3 Joint Undertaking presents an opportunity to support better integration through partnerships between African and European organizations working on collaborative research. A key element of the partnership will be the Global Health Network (tGHN)\u2019s support to Global South leadership and the creation of an enabling environment for improved health research and data science capabilities through tGHN\u2019s \u2018Ecosystem for Health Research &amp; Data Science\u2019 initiative.<sup><a target=_self href=#fn2 id=r2>[2]</a></sup></p><p><u>This partnership aims to: </u></p><ol level=\"0\">  <li>Increase the use of genomic epidemiology by Africa CDC and NPHIs across Africa to answer public health questions of most concern nationally and regionally.</li><li>Create data platforms through which integrated epidemiologic, clinical, and genomic data can be collected and combined by African researchers and NPHIs.</li><li>Pilot selected projects of translational research for the application of genomic epidemiology for specific pathogens/disease areas in low- and middle-income countries (LMICs), translating these applications to inform public health decision-making and/or product development.</li><li>Establish a community of practice, training programmes, and fellowship opportunities in genomic epidemiology, increasing the literacy of genomics experts in the principles and methods of epidemiology and of epidemiologists in the use of genomic data.</li> </ol><p>The collaboration is being implemented through two topics.</p><p>Through the topic GH-EDCTP3-2022-CALL1-01-03 within this collaboration presented here, funding from the Global Health EDCTP3 JU is made available. This will be complemented by the grant to identified beneficiaries (Other Action 2 HORIZON-JU-GH-EDCTP3-2022-OA2) which supports coordination activities for the collaboration and brings together the contribution from the Bill &amp; Melinda Gates Foundation. <strong>Applicants to each of the topics are strongly encouraged to read the topic description for both topics: GH-EDCTP3-2022-CALL1-01-03 and Other Action 2 HORIZON-JU-GH-EDCTP3-2022-OA2.</strong></p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>Proposals should address all of the following:</p><ul level=\"0\"><li>Strengthen countries\u2019 capacity for early detection and/or characterization of any poverty-related infectious diseases (PRDs) disease, group of PRDs or emerging or re-emerging infectious disease affecting sub-Saharan Africa and that are within the scope of the current EDCTP3 programme<sup><a target=_self href=#fn3 id=r3>[3]</a></sup>. In view of the amount of work already carried out, this call topic excludes proposals working on genomic epidemiology in the context of COVID-19;</li><li>Implement at least one selected project of translational research demonstrating the application of genomic epidemiology to answer specific public health questions pertaining to infectious diseases. These projects should go beyond the generation of data. They should include translation to decision making through active engagement with public health officials and other stakeholders. Examples of potential projects demonstrating the application of genomic epidemiology to answer specific public health questions pertaining to infectious diseases could include investigation of the burden, transmission, or evolution of a pathogen, investigation of the pathogens causing a specific disease/clinical presentation, characterization of a pathogen to inform product development/ public health intervention design, evaluation of the effect of public health interventions (such as vaccination programmes) on the epidemiology of a pathogen. Public health areas that are not mentioned as an example but apply genomic epidemiology and are of relevance for public health decision-making and/or product or intervention design will also be considered;</li><li>Proposals are expected to partner with National Public Health Institutes (with the support of the Africa Pathogen Genomics Initiative (PGI) as described in Other Action 2 HORIZON-JU-GH-EDCTP3-2022-OA2);</li><li>Proposals should explicitly outline how proposed partnerships with NPHI or other government entities will support definition of questions of greatest public health importance and allow applicants to leverage and integrate the use of genomic sequencing in Africa to answer the prioritized public health questions through integration with epidemiology data and approaches;</li><li>Integrate epidemiologic, clinical, and genomic data through data integration platforms, with the need for this integration built into the design of the research study/surveillance programmes prior to data collection. Collaboration with the Global Health Network and harmonization across awarded projects (see Other Action 2 HORIZON-JU-GH-EDCTP3-2022-OA2) is expected for the development of these data platforms, which should also leverage experiences and tools from existing initiatives such as the European COVID-19 Data Platform<sup><a target=_self href=#fn4 id=r4>[4]</a></sup>, the Public Health Alliance for Genomic Epidemiology (PHA4GE)<sup><a target=_self href=#fn5 id=r5>[5]</a></sup>, the Global Alliance for Genomics &amp; Health (GA4GH)<sup><a target=_self href=#fn6 id=r6>[6]</a></sup> and/or the European Union-funded BY-COVID project<sup><a target=_self href=#fn7 id=r7>[7]</a></sup>;</li><li>Strengthen and harmonize data standards and tools to enable the integration of epidemiological and genomics data collection, storage, sharing, and analysis. Collaboration with the Global Health Network and PHA4GE is expected for this task (see Other Action 2 HORIZON-JU-GH-EDCTP3-2022-OA2);</li><li>Proposals should ensure that resulting data comply with the FAIR principles and collaboration with the future awardee of HORIZON-WIDERA-2021-ERA-01-41<sup><a target=_self href=#fn8 id=r8>[8]</a></sup> is encouraged to increase international cooperation on FAIR data;</li><li>Establish a community of practice on genomic epidemiology including expertise in bioinformatics to increase the literacy of genomics experts in the principles and methods of epidemiology and the literacy of epidemiologists on the use of genomic data. This community of practice will be formed in collaboration with the consortium under the grant agreement of Other Action 2 HORIZON-JU-GH-EDCTP3-2022-OA2 which could include : Global Health Network and the Africa PGI, as well as linking to existing communities of practice established through PHA4GE, the EDCTP\u2019s Network of Excellence<sup><a target=_self href=#fn9 id=r9>[9]</a></sup>, and the African Society for Laboratory Medicine (ASLM)<sup><a target=_self href=#fn10 id=r10>[10]</a></sup>;</li><li>Support the generation of harmonized training resources, including for young African scientists with gender balance through degree training in genomic epidemiology and/or hands on training during implementation of research projects to assist them in advancing their scientific careers. Training resources should be developed in collaboration with the consortium under grant agreement of Other Action 2 HORIZON-JU-GH-EDCTP3-2022-OA2 including Africa PGI\u2019s Next-Generation Sequencing (NGS) Academy and the Global Health Network for: 1) genomic expertise in the principles, methods, and application of epidemiology methods; 2) epidemiologists in the principles, methods, and applications of genomics; 3) both communities in the combined principles, methods, and applications of genomic epidemiology and its use for public health decision making and surveillance programmes. It is expected that training will be harmonized across funded projects and collaboration with existing initiatives and projects, such as the awarded projects under the EDCTP2\u2019s CSA2020E<sup><a target=_self href=#fn11 id=r11>[11]</a></sup>, EDCTP\u2019s Networks of Excellence, ECDC4Africa CDC initiative<sup><a target=_self href=#fn12 id=r12>[12]</a></sup> and EDCTP\u2019s Knowledge Hub<sup><a target=_self href=#fn13 id=r13>[13]</a></sup>, should be sought where possible;</li><li>Promote the integration of research with public health organizations and disease control programmes at a national and regional level. Collaboration between relevant stakeholders in National Public Health Institutes and academic/research centres is expected at a national level. On a regional level, regional consortia and organizations such as Africa CDC, should be engaged where appropriate;</li><li>Proposals should include organizations with expertise in epidemiology and those with expertise in genomics, with a willingness to work together to establish joint projects and achieve the aims outlined above;</li><li>Proposals should consider gender equality in the design of their projects and justify how they will be gender intentional in their proposed aims and activities.</li> </ul>\n<SPAN class=\"topicdescriptionkind\">Cross-cutting Priorities</SPAN>:<p><a href=\"//ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-search;statusCodes=31094501,31094502,31094503;programCcm2Id=43108390;crossCuttingPriorityCode=EC-WORLD;sortQuery=sortStatus;orderBy=asc\">International Cooperation</a><br><a href=\"//ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-search;statusCodes=31094501,31094502,31094503;programCcm2Id=43108390;crossCuttingPriorityCode=EoscAndFairData;sortQuery=sortStatus;orderBy=asc\">EOSC and FAIR data</a><br><a href=\"//ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-search;statusCodes=31094501,31094502,31094503;programCcm2Id=43108390;crossCuttingPriorityCode=Africa;sortQuery=sortStatus;orderBy=asc\">Africa</a><br></p>\n<p id=fn1><a  target=_self href=#r1>[1]</a>https://ipg.africacdc.org/</p><p id=fn2><a  target=_self href=#r2>[2]</a>https://tghn.org/</p><p id=fn3><a  target=_self href=#r3>[3]</a><a href=\"https://ec.europa.eu/info/sites/default/files/research_and_innovation/research_by_area/documents/ec_rtd_edctp3-sria-2022.pdf\">ec_rtd_edctp3-sria-2022.pdf (europa.eu)</a></p><p id=fn4><a  target=_self href=#r4>[4]</a><a href=\"https://www.covid19dataportal.org/the-european-covid-19-data-platform\">The European COVID-19 Data Platform : COVID-19 Data Portal (covid19dataportal.org)</a></p><p id=fn5><a  target=_self href=#r5>[5]</a><a href=\"https://pha4ge.org/\">PHA4GE - Genomic Epidemiology</a></p><p id=fn6><a  target=_self href=#r6>[6]</a><a href=\"https://www.ga4gh.org/news/data-use-ontology-approved-as-a-ga4gh-technical-standard/\">Data Use Ontology approved as a GA4GH technical standard</a></p><p id=fn7><a  target=_self href=#r7>[7]</a><a href=\"https://by-covid.org/\">BY-COVID | BY-COVID</a></p><p id=fn8><a  target=_self href=#r8>[8]</a><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-widera-2021-era-01-41;callCode=null;freeTextSearchKeyword=Global%20cooperation%20on%20FAIR%20data%20policy%20and%20%20practice;matchWholeText=true;typeCodes=1,0;statusCodes=31094501,31094502,31094503;programmePeriod=null;programCcm2Id=null;programDivisionCode=null;focusAreaCode=null;destination=null;mission=null;geographicalZonesCode=null;programmeDivisionProspect=null;startDateLte=null;startDateGte=null;crossCuttingPriorityCode=null;cpvCode=null;performanceOfDelivery=null;sortQuery=sortStatus;orderBy=asc;onlyTenders=false;topicListKey=topicSearchTablePageState\">Funding &amp; tenders (europa.eu)</a></p><p id=fn9><a  target=_self href=#r9>[9]</a><a href=\"https://www.edctp.org/networks-excellence/\">Networks of Excellence - EDCTP</a></p><p id=fn10><a  target=_self href=#r10>[10]</a><a href=\"https://aslm.org/\">Home - African Society for Laboratory Medicine (aslm.org)</a></p><p id=fn11><a  target=_self href=#r11>[11]</a><a href=\"https://www.edctp.org/call/capacity-development-for-disease-outbreak-and-epidemic-response-in-sub-saharan-africa-in-collaboration-with-africa-cdc/\">Capacity development for disease outbreak and epidemic response in sub-Saharan Africa, in collaboration with Africa CDC - 2020 - EDCTP</a></p><p id=fn12><a  target=_self href=#r12>[12]</a><a href=\"https://www.ecdc.europa.eu/en/news-events/eu-and-au-sign-partnership-scale-preparedness-health-emergencies\">EU and AU sign partnership to scale up preparedness for health emergencies (europa.eu)</a></p><p id=fn13><a  target=_self href=#r13>[13]</a><a href=\"https://www.edctp.org/our-work/edctp-knowledge-hub/\">EDCTP Knowledge Hub - EDCTP</a></p>", "conditions": "<p><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:11.0pt;line-height:115%;&#10;font-family:&quot;Calibri&quot;,sans-serif;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:&#10;Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;&#10;mso-bidi-font-family:&quot;Times New Roman&quot;;mso-bidi-theme-font:minor-bidi;&#10;color:#404040;mso-themecolor:text1;mso-themetint:191;mso-ansi-language:EN-US;&#10;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\">General conditions</span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">1. Admissibility conditions: </span></b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US;&#10;mso-bidi-font-weight:bold\">described in </span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex A</a></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US;mso-bidi-font-weight:&#10;bold\"> and </span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:&#10;Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex E</a></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US;mso-bidi-font-weight:&#10;bold\"> of the Horizon Europe Work Programme General Annexes</span></p>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\" style=\"mso-ansi-language:&#10;EN-US\"> described in Part B of the Application Form available in the Submission System</span></p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\n<p><b><span lang=\"EN-US\">2. Eligible countries:&nbsp;</span></b></p>\r\n<p><span lang=\"EN-US\" style=\"font-size: 11pt; line-height: 15.6933px; font-family: Calibri, sans-serif;\">According to Article 110 of the Council Regulation (EU) 2021/2085, funding from the&nbsp; Global Health EDCTP3 Joint Undertaking is restricted to legal entities established in Member States or associated countries or in the constituent states of the EDCTP Association.</span></p>\r\n<p><span lang=\"EN-US\" style=\"font-size: 11pt; line-height: 15.6933px; font-family: Calibri, sans-serif;\">Constituent states of the EDCTP Association that are not Member States or associated countries are: Burkina Faso, Cameroon, Congo, C&ocirc;te d&rsquo;Ivoire, Ethiopia, Gabon, The Gambia, Ghana,&nbsp;</span><span style=\"font-family: Calibri, sans-serif; font-size: 14.6667px;\">Kenya,</span><span style=\"font-family: Calibri, sans-serif; font-size: 14.6667px;\">&nbsp;</span><span style=\"font-family: Calibri, sans-serif; font-size: 11pt;\">Mali, Mozambique, Niger, Nigeria, Senegal, South Africa, Tanzania, Uganda, United Kingdom, Zambia.</span></p>\r\n<p><span lang=\"EN-US\">A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the&nbsp;</span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\">Horizon Europe Programme Guide</a></span><span lang=\"EN-US\">.</span></p>\r\n<p>&nbsp;</p>\n<p>&nbsp;<b><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\">&nbsp;described in&nbsp;</span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex B</a></span>&nbsp;<span lang=\"EN-US\">of the Work Programme General Annexes,&nbsp;</span>except for the specific conditions for GH EDCTP3 funding as regards&nbsp;<u>Entities eligible for funding</u>&nbsp;and&nbsp;<u>Consortium composition.</u></p>\r\n<p class=\"MsoNormal\"><i><u><span lang=\"EN-IE\">Entities eligible to participate<o:p></o:p></span></u></i></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span lang=\"EN-IE\">Given the illegal invasion of Ukraine by Russia and the involvement of Belarus, there is currently no appropriate context allowing the implementation of the actions foreseen in this programme with legal entities established in Russia, Belarus, or in non-government controlled territories of Ukraine. Therefore, such legal entities are not eligible to participate in any capacity. This criterion also applies in cases where the action involves financial support given by grant beneficiaries to third parties established in Russia, Belarus or in non-government controlled territories of Ukraine (in accordance with Article 204 of the Financial Regulation No 2018/1046).<b><u><o:p></o:p></u></b></span></p>\r\n<p class=\"MsoNormal\"><i><u><span lang=\"EN-IE\">Entities eligible for funding<o:p></o:p></span></u></i></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-IE\">To be eligible for funding, applicants must be eligible to participate and established in one of the eligible countries, i.e.<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"text-indent: -18pt; line-height: 12.6px;\"><span lang=\"EN-IE\">-<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-IE\">The Member States of the European Union, including their outermost regions;<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"text-indent: -18pt; line-height: 12.6px;\"><span lang=\"EN-IE\">-<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-IE\">The Oversees Countries and Territories (OCTs) linked to Member States<a href=\"file:///C:/Users/crisaal/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/32LODOYY/Topic%20Conditions%20new.docx#_ftn1\" name=\"_ftnref1\" title=\"\"><span class=\"MsoFootnoteReference\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-IE\" style=\"font-size: 11pt; line-height: 15.6933px; font-family: Calibri, sans-serif;\">[1]</span></span></span></a><o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"text-indent: -18pt; line-height: 12.6px;\"><span lang=\"EN-IE\">-<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-IE\">Eligible non-EU countries:<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left: 72pt; text-indent: -18pt; line-height: 12.6px;\"><span lang=\"EN-IE\" style=\"font-family: &quot;Courier New&quot;;\">o<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-IE\">Countries associated to Horizon Europe<a href=\"file:///C:/Users/crisaal/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/32LODOYY/Topic%20Conditions%20new.docx#_ftn2\" name=\"_ftnref2\" title=\"\"><span class=\"MsoFootnoteReference\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-IE\" style=\"font-size: 11pt; line-height: 15.6933px; font-family: Calibri, sans-serif;\">[2]</span></span></span></a><o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left: 72pt; text-indent: -18pt; line-height: 12.6px;\"><span lang=\"EN-IE\" style=\"font-family: &quot;Courier New&quot;;\">o<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-IE\">Countries that are members of the EDCTP Association<a href=\"file:///C:/Users/crisaal/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/32LODOYY/Topic%20Conditions%20new.docx#_ftn3\" name=\"_ftnref3\" title=\"\"><span class=\"MsoFootnoteReference\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-IE\" style=\"font-size: 11pt; line-height: 15.6933px; font-family: Calibri, sans-serif;\">[3]</span></span></span></a><o:p></o:p></span></p>\r\n<p><span lang=\"EN-IE\" style=\"font-size: 11pt; line-height: 15.6933px; font-family: Calibri, sans-serif;\">Legal entities which are established in countries not listed above will be eligible for funding if provided for in the specific call conditions, or if the participation is considered essential for implementing the action by the granting authority.</span></p>\r\n<div><br clear=\"all\" />\r\n<hr align=\"left\" size=\"1\" width=\"33%\" />\r\n<div id=\"ftn1\">\r\n<p class=\"MsoFootnoteText\"><a href=\"file:///C:/Users/crisaal/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/32LODOYY/Topic%20Conditions%20new.docx#_ftnref1\" name=\"_ftn1\" title=\"\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-US\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-US\" style=\"font-size: 10pt; line-height: 14.2667px; font-family: Calibri, sans-serif;\">[1]</span></span></span></span></a><span lang=\"EN-US\">&nbsp;</span><span lang=\"EN-IE\">Entities from Oversees Countries and Territories (OCT) are eligible for funding under the same conditions as entities from the Member State to which the OCT in question is linked. See the&nbsp;</span><span lang=\"EN-US\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\"><span lang=\"EN-IE\">Horizon Europe Programme Guide</span></a></span><span lang=\"EN-IE\">&nbsp;for a complete list of OCTs.</span><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n</div>\r\n<div id=\"ftn2\">\r\n<p class=\"MsoFootnoteText\"><a href=\"file:///C:/Users/crisaal/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/32LODOYY/Topic%20Conditions%20new.docx#_ftnref2\" name=\"_ftn2\" title=\"\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-US\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-US\" style=\"font-size: 10pt; line-height: 14.2667px; font-family: Calibri, sans-serif;\">[2]</span></span></span></span></a><span lang=\"EN-US\">&nbsp;</span><span lang=\"EN-IE\">See list of&nbsp;</span><span lang=\"EN-US\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/list-3rd-country-participation_horizon-euratom_en.pdf\"><span lang=\"EN-IE\">associated countries</span></a></span><span class=\"MsoHyperlink\"><span lang=\"EN-IE\">&nbsp;and&nbsp;<a href=\"https://ec.europa.eu/info/research-and-innovation/strategy/strategy-2020-2024/europe-world/international-cooperation_en\" target=\"_blank\">International Cooperation</a></span></span><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n</div>\r\n<div id=\"ftn3\">\r\n<p class=\"MsoFootnoteText\"><a href=\"file:///C:/Users/crisaal/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/32LODOYY/Topic%20Conditions%20new.docx#_ftnref3\" name=\"_ftn3\" title=\"\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-US\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-US\" style=\"font-size: 10pt; line-height: 14.2667px; font-family: Calibri, sans-serif;\">[3]</span></span></span></span></a><span lang=\"EN-US\">&nbsp;</span><span lang=\"EN-IE\">See the&nbsp;</span><span lang=\"EN-US\"><a href=\"http://www.edctp.org/about-us/governance/general-assembly/members-of-the-general-assembly/\"><span lang=\"EN-IE\">EDCTP website</span></a></span></p>\r\n</div>\r\n</div>\r\n<p>&nbsp;</p>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><b>4. Financial and operational capacity and exclusion: </b><span style=\"mso-bidi-font-weight:bold\">described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex C</a> of the Work Programme General Annexes</span></p>\r\n<p>&nbsp;</p>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><b><span lang=\"FR-BE\" style=\"mso-ansi-language:FR-BE\">5.&nbsp;Evaluation and award:</span></b></p>\r\n<p>&nbsp;</p>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\"><b><span lang=\"EN-US\">Award criteria&nbsp;</span></b><span lang=\"EN-US\">&nbsp;are described in&nbsp;</span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex D</a></span><span lang=\"EN-US\">&nbsp;of the Work Programme General Annexes.</span></li>\r\n    <li class=\"MsoNormal\">\r\n    <p class=\"MsoNormal\"><strong><span lang=\"EN-US\">Scoring and thresholds</span></strong><span lang=\"EN-US\">&nbsp;are as follows:<o:p></o:p></span></p>\r\n    <p class=\"MsoNormal\" style=\"text-align: justify;\"><span lang=\"EN-IE\">Evaluation scores will be awarded for the criteria, and not for the different aspects listed in the table. For full applications, each criterion will be scored out of 5. The threshold for individual criteria 1 (Excellence) and 2 (Impact) will be 4 and for criteria 3 (Quality and efficiency of the implementation) will be 3. The overall threshold, applying to the sum of the three individual scores, will be 12.<o:p></o:p></span></p>\r\n    <span lang=\"EN-IE\" style=\"font-size: 11pt; line-height: 15.6933px; font-family: Calibri, sans-serif;\">Proposals that pass the individual threshold AND the overall threshold will be considered for funding, within the limits of the available call budget. Other proposals will be rejected.</span></li>\r\n</ul>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\"><b><span lang=\"EN-US\">Submission and evaluation      processes</span></b><span lang=\"EN-US\"> are      described in </span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex      F</a></span><span lang=\"EN-US\"> of      the Work Programme General Annexes and the </span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\">Online      Manual</a><span lang=\"EN-US\"><o:p></o:p></span></li>\r\n</ul>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\"><b><span lang=\"EN-US\">Indicative timeline for      evaluation and grant agreement: </span></b><span lang=\"EN-US\">described in </span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex      F</a></span><span lang=\"EN-US\"> of the Work Programme General Annexes</span><span lang=\"EN-US\"><o:p></o:p></span></li>\r\n</ul>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><b style=\"mso-bidi-font-weight:normal\"><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">6. Legal and financial set-up of the grants: </span></b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">described in </span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:&#10;minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex G</a></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\"> of the Work Programme General Annexes<o:p></o:p></span></p>\r\n<p>&nbsp;</p>\n<p>Grants awarded under this topic will be linked to the following actions: Grants awarded under this topic and grants awarded under the corresponding topic under this collaboration Other Action 2 HORIZON-JU-GH-EDCTP3-2022-OA2. Signing of a collaboration agreement as linked actions in accordance with Article 7 of the Model Grant Agreement will be required.</p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\">Specific conditions<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\">7. Specific conditions: </span></b><span lang=\"EN-US\">described in the specific topic of the Work Programme<o:p></o:p></span></p>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\">Documents<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">Call documents:<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US;mso-bidi-font-weight:bold\">Standard application form &mdash;<i style=\"mso-bidi-font-style:normal\"> call-specific application form is available in the Submission System</i><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/af_he-ria-ia_en.pdf\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin\">Standard application form (HE RIA, IA)</span></a><span style=\"color:#404040;mso-themecolor:&#10;text1;mso-themetint:191;mso-ansi-language:EN-US;mso-bidi-font-weight:bold\"> <span lang=\"EN-US\"><o:p></o:p></span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">Standard evaluation form </span><span lang=\"EN-US\">&mdash;<i> will be used with the necessary adaptations</i></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/ef/ef_he-ria-ia_en.pdf\"><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US;mso-bidi-font-weight:bold\">Standard evaluation form (HE RIA, IA)</span></a><span lang=\"EN-US\" style=\"color:#404040;&#10;mso-themecolor:text1;mso-themetint:191;mso-ansi-language:EN-US;mso-bidi-font-weight:&#10;bold\"> <o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"color: rgb(64, 64, 64);\">MGA</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:&#10;191.4pt\"><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-weight:bold\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/general-mga_horizon-euratom_en.pdf\">HE <span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">General MGA v1.1</span></a></span></span><span class=\"MsoHyperlink\"><span style=\"mso-ansi-language:EN-US;mso-bidi-font-weight:&#10;bold\"> <span lang=\"EN-US\"><o:p></o:p></span></span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:&#10;191.4pt\">&nbsp;</p>\r\n<p>&nbsp;</p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\">Additional documents:<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><a href=\"https://ec.europa.eu/info/sites/default/files/research_and_innovation/research_by_area/documents/ec_rtd_global-health-edctp3-wp-annex1.pdf\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">GH EDCTP3 JU Work Programme 2022</a></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><b><span lang=\"EN-US\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">HE Main Work Programme 2021&ndash;2022 &ndash; 13. General Annexes</a></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/rules-lev-lear-fca_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment</a></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/aga_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\"><span lang=\"EN-US\">EU Grants AGA&nbsp;</span>&mdash; Annotated Model Grant Agreement</a></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">&nbsp;</p>\r\n<ul style=\"padding: 0px; margin: 3px 0px 3px 30px; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">\r\n    <li style=\"padding: 0px; margin: 0px; color: rgb(51, 51, 51); line-height: 1.4; list-style-type: square;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.L_.2021.427.01.0017.01.ENG&amp;toc=OJ%3AL%3A2021%3A427%3ATOC\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">GH EDCTP3 JU Regulation of Establishment</a></li>\r\n    <li style=\"padding: 0px; margin: 0px; color: rgb(51, 51, 51); line-height: 1.4; list-style-type: square;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">HE Programme guide</a></li>\r\n    <li style=\"padding: 0px; margin: 0px; color: rgb(51, 51, 51); line-height: 1.4; list-style-type: square;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0695\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">HE Framework Programme and rules for Participation Regulation&nbsp; 2021/695</a></li>\r\n    <li style=\"padding: 0px; margin: 0px; color: rgb(51, 51, 51); line-height: 1.4; list-style-type: square;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021D0764\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">HE Specific Programme Decision 2021/764</a></li>\r\n    <li style=\"padding: 0px; margin: 0px; color: rgb(51, 51, 51); line-height: 1.4; list-style-type: square;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">EU Financial Regulation</a></li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Funding &amp; Tenders Portal Online Manual</span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/tc_en.pdf\">Funding &amp; Tenders Portal Terms and Conditions</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"font-size:11.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;&#10;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:&#10;minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:&quot;Times New Roman&quot;;&#10;mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-GB;mso-fareast-language:&#10;EN-US;mso-bidi-language:AR-SA\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/privacy-statement_en.pdf\">Funding &amp; Tenders Portal Privacy Statement</a></span></p>", "supportInfo": "<p><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;font-weight:normal;mso-bidi-font-weight:bold\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><b>Online Manual&nbsp;</b></a></span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">is your guide on the procedures from proposal submission to managing your grant.<o:p></o:p></span></p>\r\n<p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Horizon Europe Programme Guide</span></b></a><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;</span></strong><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif; font-weight: normal;\">contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;type=undefined;categories=;programme=H2020;actions=;keyword=\" target=\"_blank\">Funding &amp; Tenders Portal FAQ</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/research-and-innovation/contact/research-enquiry-service_en\" target=\"_blank\">Research Enquiry Service</a></span>&nbsp;</b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.</span></p>\r\n<p><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/ncp\" target=\"_blank\">National Contact Points (NCPs)</a>&nbsp;</span></b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; get guidance, practical information and assistance on participation in Horizon Europe. There are also NCPs in many non-EU and non-associated countries (&lsquo;third-countries&rsquo;).<b><o:p></o:p></b></span></p>\r\n<p><a href=\"https://een.ec.europa.eu/\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Enterprise Europe Network</span></b></a><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;color:#003366\">&nbsp;</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\" target=\"_blank\">IT Helpdesk</a></span></b>&nbsp;</span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash;&nbsp;contact the Funding &amp; Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://www.iprhelpdesk.eu/\" target=\"_blank\">European IPR Helpdesk</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;assists you on intellectual property issues.<br />\r\n<br />\r\n</span><b><a href=\"mailto:research@cencenelec.eu\" target=\"_blank\">CEN-CENELEC Research Helpdesk</a> and <a href=\"https://www.etsi.org/research/helpdesk\" target=\"_blank\">ETSI Research Helpdesk</a></b>&nbsp;<span style=\"font-family: Arial, sans-serif;\">&ndash;&nbsp;&nbsp;</span>the European Standards Organisations&nbsp;advise you how to tackle standardisation in your project proposal.&nbsp;&nbsp;</p>\r\n<p class=\"MsoNormal\" style=\"margin-left:36.0pt\"><o:p></o:p></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://euraxess.ec.europa.eu/sites/default/files/am509774cee_en_e4.pdf\" target=\"_blank\">The European Charter for Researchers and the Code of Conduct for their recruitment</a></span></b></span><strong><u><span style=\"font-size:&#10;9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366\"> </span></u></strong><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366;font-weight:&#10;normal;mso-bidi-font-weight:bold\">&ndash; consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.</span></strong><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></b></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/partner-search\" target=\"_blank\">Partner Search Services</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;help you find a partner organisation for your proposal.<o:p></o:p></span></p>\r\n<p>&nbsp;</p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"additionalInfo": "", "staticAdditionalInfo": "<p>The general conditions relating to this call are those applicable to the 2021/2022 work programme of Global Health EDCTP3 outlined above.</p><p><u>Expected impacts of Call 1</u></p><p>Activities funded under this call for proposals should contribute to:</p><ul level=\"0\"><li>Achieve SDG3 \u2018Ensure healthy lives and promote well-being for all at all ages\u2019 in sub-Saharan African countries;</li><li>Provide evidence for informed health policies and guidelines within public health systems in sub-Saharan Africa and at international level;</li><li>Strengthen clinical research capability in sub-Saharan Africa to rapidly respond to emerging epidemics;</li><li>Enable a regulatory environment that can ensure effective development, delivery, and uptake of new or improved safe health technologies guaranteeing that trials in sub-Saharan African countries meet international standards;</li><li>Enable countries in sub-Saharan Africa to better understand pathogen epidemiology and support effective public health monitoring through integration of genomics and epidemiology;</li><li>Increase cost effectiveness of public investment through collaboration of funders of clinical trials in the area of infectious diseases in sub-Saharan Africa;</li><li>Strengthen health systems to ensure uptake of effective health technologies and innovations;</li><li>Enhance sustainable global scientific collaboration in health research and international cooperation across sub-Saharan Africa.</li> </ul>\n", "latestInfos": [{"approvalDate": "Dec 22, 2022 8:21:02 AM", "lastChangeDate": "Dec 22, 2022 8:21:02 AM", "content": "<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">Information for the Funding Portal<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">Number proposals submitted: 92<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">Number Ineligible proposals: 11<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">Number proposals evaluated: 81<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - Number of Below threshold: 36<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - Number of Above threshold: 45<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - Number of Main list: 26<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - Number of Reserve list: 4<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - Number rejected due to budgetary ressources: 15<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">Number of proposal upgraded from Reserve list to Main list: 1</span></b><span lang=\"EN-IE\"><o:p></o:p></span></p>"}, {"approvalDate": "May 17, 2022 4:30:46 PM", "lastChangeDate": "May 17, 2022 4:30:46 PM", "content": "The submission session is now available for: HORIZON-JU-GH-EDCTP3-2022-CALL1-01-01(HORIZON-JU-RIA), HORIZON-JU-GH-EDCTP3-2022-CALL1-01-04(HORIZON-JU-CSA), HORIZON-JU-GH-EDCTP3-2022-CALL1-01-03(HORIZON-JU-RIA), HORIZON-JU-GH-EDCTP3-2022-CALL1-01-02(HORIZON-JU-RIA), HORIZON-JU-GH-EDCTP3-2022-CALL1-01-05(HORIZON-JU-CSA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}